TITLE

YOUR MONEY

PUB. DATE
March 2007
SOURCE
Health (Time Inc.);Mar2007, Vol. 21 Issue 2, p98
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents question and answers related to personal finance. One person asks whether he should ask his doctor for a generic drug instead of a more expensive brand name drug when he needs a prescription. He is advised that he should since drug effectiveness experts have found that generics can be used effectively to treat most common conditions that require medication.
ACCESSION #
24306947

 

Related Articles

  • Slash your health care spending. Ashford, Kate // All You;2/22/2013, Vol. 10 Issue 2, p101 

    The article offers suggestions to control the spending on health care. It is recommended to ask for discounts on various medical therapy services. Use of generic medicines that have same active ingredient as that of brand-name medicines at a low price is also suggested. It also advises to ask...

  • Congress appeals to FDA to curb GATT's volatility. Rankin, Ken // Drug Store News;5/22/95, Vol. 17 Issue 7, p9 

    Focuses on letter sent by a bipartisan group of senators to Food and Drug Administration (FDA) Commissioner David Kessler, warning of the possible effect of the General Agreement on Tariffs and Trade (GATT) on generic introductions and cost of prescription drugs. Issue over the GATT provision...

  • Finding the win--win: Issues to consider when undertaking brand substitution. Carroll, Peter R. // Australian Journal of Pharmacy;Mar2011, Vol. 92 Issue 1090, p70 

    The article presents an overview of the introduction of the generic alternatives to original brand medicines in Australia. It notes that the introduction has reduced the amount the government has to pay for medicines under the Pharmaceutical Benefits Scheme (PBS). Furthermore, the significant...

  • CMS: Generic drug utilization on the rise.  // Healthcare Purchasing News;Mar2007, Vol. 31 Issue 3, p6 

    The article reports on the increase in the use of generic drug in the U.S. according to data released by the Centers for Medicare & Medicaid Services (CMS). The CMS data demonstrate that generic drug utilization is high among those in the new Medicare drug benefit. Its distribution has risen...

  • Some Medicare patients might save by swapping drugs.  // Journal of Business (10756124);9/26/2013, Vol. 28 Issue 20, pB8 

    The article reports on the study led by the University of California, Los Angeles (UCLA) published in the "Journal of General Internal Medicine," which suggests that substituting brand name therapeutics with less expensive counterparts with similar effect can help Medicare patient save money.

  • Rx Interventions Improve Outcomes.  // MMR;11/16/2015, Vol. 32 Issue 17, p29 

    The article discusses findings of a study released by the Walgreens Co. which claim that pharmacy interventions for patients who started new medications have improve outcomes and reduced overall health care costs in the U.S.

  • ENTRY FORMAT.  // Monthly Prescribing Reference;Feb2013, Vol. 29 Issue 2, Special section pA-12 

    The article offers information on the entry format of pharmaceuticals. It informs that the therapeutic and the chemical class of the drug should be listed in italics. It highlights that the name of the manufacturer must be included in the format to provide accessibility for more medial...

  • ENTRY FORMAT.  // MPR - Urologists' Edition;Spring/Summer2012, Vol. 9 Issue 1, pA.13 

    The article offers information on the entry format for drug literatures. It notes that the chemical and therapeutic class of the drug should be listed in italics. It adds that the name of the manufacturer must be included in the format to provide accessibility for more medial information....

  • Who's winning NTI substitution war--brands or generics? Epstein, Debbie // Drug Topics;9/15/97, Vol. 141 Issue 18, p70 

    Focuses on the battle over generic substitution for narrow therapeutic index (NTI) drugs in the United States. Information on the state which has adopted regulations against NTI substitution; Comments from Charles M. Mayr, director of corporate communications for Barr Laboratories Incorporated;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics